Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway (Q38812002)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 December 2015

Language	Label	Description	Also known as
English	Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway	scientific article published on 12 December 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

apoptotic process

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Ming-Te Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chia-Liang Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Tzu-Yu Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chun-Wen Cheng

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Shun-Fa Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chu-Liang Lin

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Chih-Chien Wu

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Yi-Hsien Hsieh

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Jen-Pi Tsai

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

6987-6996

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Update on novel therapeutic agents for cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Adverse effects of anticancer agents that target the VEGF pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Death receptor-induced cell killing

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The apoptosome: signalling platform of cell death

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Mitochondrial cytochrome c biogenesis: no longer an enigma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Bcl-2 protein family members: versatile regulators of calcium signaling in cell survival and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The prognostic value of TRAIL and its death receptors in cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Modern management of locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Dietary flavonoids: effects on xenobiotic and carcinogen metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Apoptosis by dietary agents for prevention and treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Synergistic anti-tumor effects of the combination of a benzofuroxan derivate and sorafenib on NCI-H460 human large cell lung carcinoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

NDRG4 is a novel oncogenic protein and p53 associated regulator of apoptosis in malignant meningioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Mitochondrial apoptosis: killing cancer using the enemy within.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Flavonoids: Promising anticancer agents

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Involvement of ER stress and activation of apoptotic pathways in fisetin induced cytotoxicity in human melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The TRAIL of oncogenes to apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The proto-oncogene Bcl-2 and its role in regulating apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

TRAIL induces apoptosis in oral squamous carcinoma cells--a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4526-4

21 January 2018

N-acetyl-L-cysteine enhances fisetin-induced cytotoxicity via induction of ROS-independent apoptosis in human colonic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26662956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-015-4526-4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38812002&oldid=2202098814"